Progression of aortic stenosis after an acute myocardial infarction.


Journal

Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219

Informations de publication

Date de publication:
06 2022
Historique:
received: 24 04 2022
accepted: 26 05 2022
entrez: 21 6 2022
pubmed: 22 6 2022
medline: 24 6 2022
Statut: ppublish

Résumé

Myocardial infarction (MI) has been shown to induce fibrotic remodelling of the mitral and tricuspid valves. It is unknown whether MI also induces pathological remodelling of the aortic valve and alters aortic stenosis (AS) progression. We thus compared AS progression after an acute MI and in patients with/without history of MI, and assessed post-MI pathobiological changes within the aortic valve leaflets in a sheep model. Serial echocardiograms in human patients with AS were retrospectively analysed and compared between 3 groups: (1) acute MI at baseline (n=68), (2) prior history of MI (n=45) and (3) controls without MI (n=101). Annualised progression rates of AS severity were compared between these 3 groups. In addition, aortic valves were harvested from 15 sheep: (1) induced inferior MI (n=10) and (2) controls without MI (n=5), for biological and histological analyses. In humans, the acute MI, previous MI and control groups had comparable baseline AS severity. Indexed aortic valve area (AVA The results of this study suggest that AS progression is accelerated following acute MI, which could be caused by increased collagen production and thickening of the aortic valve after the ischaemic event.

Sections du résumé

BACKGROUND
Myocardial infarction (MI) has been shown to induce fibrotic remodelling of the mitral and tricuspid valves. It is unknown whether MI also induces pathological remodelling of the aortic valve and alters aortic stenosis (AS) progression. We thus compared AS progression after an acute MI and in patients with/without history of MI, and assessed post-MI pathobiological changes within the aortic valve leaflets in a sheep model.
METHODS
Serial echocardiograms in human patients with AS were retrospectively analysed and compared between 3 groups: (1) acute MI at baseline (n=68), (2) prior history of MI (n=45) and (3) controls without MI (n=101). Annualised progression rates of AS severity were compared between these 3 groups. In addition, aortic valves were harvested from 15 sheep: (1) induced inferior MI (n=10) and (2) controls without MI (n=5), for biological and histological analyses.
RESULTS
In humans, the acute MI, previous MI and control groups had comparable baseline AS severity. Indexed aortic valve area (AVA
CONCLUSIONS
The results of this study suggest that AS progression is accelerated following acute MI, which could be caused by increased collagen production and thickening of the aortic valve after the ischaemic event.

Identifiants

pubmed: 35728891
pii: openhrt-2022-002046
doi: 10.1136/openhrt-2022-002046
pmc: PMC9214429
pii:
doi:

Substances chimiques

Collagen 9007-34-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL136431
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141917
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL147095
Pays : United States
Organisme : CIHR
ID : 399323
Pays : Canada

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Nat Rev Dis Primers. 2016 Mar 03;2:16006
pubmed: 27188578
J Am Coll Cardiol. 2016 Jan 26;67(3):275-87
pubmed: 26796392
J Am Coll Cardiol. 2017 Sep 5;70(10):1232-1244
pubmed: 28859786
Am J Cardiol. 2010 Mar 1;105(5):701-8
pubmed: 20185020
JACC Cardiovasc Imaging. 2019 Jan;12(1):205-206
pubmed: 30621992
J Am Coll Cardiol. 1997 Mar 1;29(3):630-4
pubmed: 9060903
Eur Heart J. 2008 Apr;29(8):1043-8
pubmed: 18156619
Am J Cardiol. 2005 Jan 1;95(1):132-6
pubmed: 15619412
J Am Soc Echocardiogr. 2017 Apr;30(4):372-392
pubmed: 28385280
Circulation. 1997 May 6;95(9):2262-70
pubmed: 9142003
Prog Cardiovasc Dis. 2014 May-Jun;56(6):565-71
pubmed: 24838132
N Engl J Med. 2008 Sep 25;359(13):1343-56
pubmed: 18765433
Lancet. 2006 Sep 16;368(9540):1005-11
pubmed: 16980116
N Engl J Med. 1999 Jul 15;341(3):142-7
pubmed: 10403851
Heart. 2014 Jun;100(12):930-7
pubmed: 24501258
J Am Coll Cardiol. 2020 Feb 4;75(4):395-405
pubmed: 32000951
Circ Cardiovasc Imaging. 2017 Nov;10(11):
pubmed: 29042413
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Eur J Cardiothorac Surg. 2009 Mar;35(3):493-504
pubmed: 19162497

Auteurs

Amélie Paquin (A)

Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.
Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Ons Marsit (O)

Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.

Valérie Deschênes (V)

Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.

Dounia Rouabhia (D)

Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.

Sandra Hadjadj (S)

Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.

Marine Clisson (M)

Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.

Charlotte Robitaille (C)

Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.

Elena Aikawa (E)

Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Robert A Levine (RA)

Cardiac Ultrasound Lab, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Philippe Pibarot (P)

Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.

Marie-Annick Clavel (MA)

Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.

Jonathan Beaudoin (J)

Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada jonathan.beaudoin@criucpq.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH